CAR-T Cell Therapy
An advanced immunotherapy in which a patient's own T-cells are genetically engineered to recognise and destroy cancer cells, then infused back into the body.
Typical price (medical tourism)
From $50,000 – $150,000
Indicative range from partner clinics; final quote varies by clinic & case.
Overview
Chimeric antigen receptor T-cell (CAR-T) therapy is a personalised cellular immunotherapy for certain blood cancers, including some lymphomas, leukaemias and multiple myeloma. A patient's T-cells are collected, genetically modified in a laboratory to express a receptor targeting a cancer-specific antigen, expanded, and then reinfused. The engineered cells multiply in the body and attack the cancer. It is a distinct treatment from stem cell transplantation, with its own indications, costs and risk profile such as cytokine release syndrome.
CAR-T Cell Therapy cost by country
Typical price range per destination (USD). Final quote varies by clinic & individual case.
